Involving Nucleic Acid Patents (Class 435/6.1)
-
Patent number: 10864226Abstract: The present invention relates to a use of microRNA(miR)-188-5p which can be used for treatment of Alzheimer's disease, and the pharmaceutical composition comprising miR-188-5p as an active ingredient of the present invention can inhibit the expression of NRP2 protein when it is added to a subject having Alzheimer's disease, thereby restoring the reduced density of dendritic spines and enhancing synaptic transmission, and thus it can prevent or treat Alzheimer's disease effectively.Type: GrantFiled: April 6, 2017Date of Patent: December 15, 2020Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATIONInventors: Hye Sun Kim, Kihwan Lee, Hyunju Kim
-
Patent number: 10858649Abstract: The present invention relates generally to the field of immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. The present invention also relates to nucleic acids encoding the immune binding proteins in which the natural multimeric association of chains is maintained in the nucleic acids and the immune binding proteins made therefrom. For example nucleic acids encoding antibodies that are amplified from a B-cell using the methods of the invention maintain the natural pairing of heavy and light chains from the B-cell. This maintenance of pairing (or multimerization) produces libraries and/or repertoires of immune binding proteins that are enriched for useful binding molecules.Type: GrantFiled: September 14, 2017Date of Patent: December 8, 2020Assignee: Augmenta Bioworks, Inc.Inventors: Christopher J. Emig, Marco Mena
-
Patent number: 10858696Abstract: The invention provides methods for amplifying nucleic acids, particularly methods for reducing density-dependent GC bias and for reducing nucleic acid damage in a bridge amplification of a nucleic acid template. The invention also provides methods for evaluating the effect of reagents and/or additives on nucleic acid damage during bridge amplification of nucleic acid template strands. The methods are suited to solid phase amplification, for example, utilizing flow cells.Type: GrantFiled: July 15, 2019Date of Patent: December 8, 2020Assignee: Illumina Cambridge LimitedInventors: Jonathan Mark Boutell, Susan Shanahan, Roberto Rigatti
-
Patent number: 10851414Abstract: The invention generally relates to methods for determining carrier status with respect to a condition or disease. In certain embodiments, the method involves exposing a sample to a plurality of molecular inversion probes capable of capturing DNA from at least one genomic region suspected of having an altered copy number and at least one internal control DNA known or suspected to have a stable copy number, capturing and sequencing DNA that binds to the molecular inversion probes, and determining a copy number state of the at least one genomic region based on the sequence results.Type: GrantFiled: October 18, 2013Date of Patent: December 1, 2020Assignee: Good Start Genetics, Inc.Inventors: Eric D. Boyden, Gregory Porreca, Mark Umbarger
-
Patent number: 10855748Abstract: A command center includes at least one network communications interface configured for two-way communications with a plurality of sites remote from the command center and at least one display screen and user interface. Each of the plurality of sites includes at least one forensic field test device configured to identify individuals using DNA samples from the individuals. The display screen and user interface are configured to depict aspects of forensic field test devices of the plurality of sites, wherein the aspects include a site identifier for each of the forensic field test devices and one or more additional aspects.Type: GrantFiled: March 2, 2018Date of Patent: December 1, 2020Assignee: INTEGENX, INC.Inventors: Robert A. Schueren, David King, Chungsoo Charles Park, Arnaldo Barican, Charles David Troup
-
Patent number: 10851357Abstract: The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences especially for use as to nucleotide repeat disorders. Provided are delivery systems and tissues or organ which are targeted as sites for delivery especially for use as to nucleotide repeat disorders. Also provided are vectors and vector systems some of which encode one or more components of a CRISPR complex or system especially for use as to nucleotide repeat disorders, as well as methods for the design and of such. Also provided are methods of directing CRISPR complex or system formation in eukaryotic cells especially for use as to nucleotide repeat disorders including with consideration of specificity for target recognition and avoidance of toxicity and editing or modifying a target site in a genomic locus of interest to alter or improve the status of a disease or a condition.Type: GrantFiled: June 10, 2016Date of Patent: December 1, 2020Assignees: THE BROAD INSTITUTE, INC., MASSACHUSETTS INSTITUTE OF TECHNOLOGY, UNIVERSITY OF IOWA RESEARCH FOUNDATIONInventors: Beverly Davidson, Chie-yu Lin, Edgardo Rodriguez, Feng Zhang
-
Patent number: 10849921Abstract: The present invention relates to compositions comprising complexes that are formed by polyinosinic-polycytidylic acid with a polyalkyleneimine, such as polyethyleneimine, that present uniform structural and functional features, as well as to processes for the preparation of said compositions that comply with regulatory requirements. The present invention additionally relates to use of said compositions as medicaments (in particular for treating cancer), alone or in combination with other therapeutic agents and/or in specific medical methods. Moreover, the administration of these compositions is associated to changes in the expression of specific genes, in cell responses, and/or in composition of immune cell populations that can be used as specific biomarkers and/or as additional target for medical treatment.Type: GrantFiled: November 17, 2017Date of Patent: December 1, 2020Inventors: Marisol Quintero Ortiz, Mercedes Pozuelo Rubio, Lourdes Planelles Carazo
-
Patent number: 10851424Abstract: Provided herein are methods for miRNA profiling for the diagnosis, prognosis, and management of melanoma and differentiation of melanoma from nevi.Type: GrantFiled: August 20, 2018Date of Patent: December 1, 2020Assignee: Quest Diagnostics Investments LLCInventors: Kevin Qu, Anthony Sferruzza, Ke Zhang, Yan Liu, Renius Owen
-
Patent number: 10849906Abstract: Provided is use of a pharmaceutical composition in treating a glucocorticoid-resistant tumor characterized by an increased level of Akt2 expression. The pharmaceutical composition comprises an Akt2 inhibitor, a glucocorticoid, and optionally a pharmaceutically acceptable carrier, excipient and/or diluent. Also provided are use of an Akt2 detecting agent in detecting a glucocorticoid-resistant tumor, and use of an Akt2 inhibitor in the preparation of a pharmaceutical composition for treating a tumor.Type: GrantFiled: November 30, 2015Date of Patent: December 1, 2020Inventor: Yanhui Xie
-
Patent number: 10844372Abstract: Methods and systems for sample preparation techniques that allow amplification (e.g., whole genome amplification) and sequencing of chromatin accessible regions of single cells are provided. The methods and systems generally operate by forming or providing partitions (e.g., droplets) including a single biological particle and a single bead comprising a barcoded oligonucleotide. The preparation of barcoded next-generation sequencing libraries prepared from a single cell is facilitated by the transposon-mediated transposition and fragmentation of a target nucleic acid sequence. The methods and systems may be configured to allow the implementation of single-operation or multi-operation chemical and/or biochemical processing within the partitions.Type: GrantFiled: December 14, 2017Date of Patent: November 24, 2020Assignee: 10X GENOMICS, INC.Inventors: Zahra Kamila Belhocine, Geoffrey McDermott, Francesca Meschi, Xinying Zheng
-
Patent number: 10837059Abstract: A method for detecting nucleic acids by (a) providing a sample having target nucleic acids, each nucleic acid having contiguous first, second, and third domains; (b) contacting the sample with probe sets to form hybridization complexes, wherein each probe set includes (i) a first probe having a sequence that is complementary to the first domain; and (ii) a second probe having a sequence substantially complementary to the third domain; (c) extending the first probes along the second domains of the complexes while the complexes are immobilized on a solid support; (d) ligating the extended first probes to the second probes to form templates; (e) amplifying the templates with primers that are complementary to the first and second priming sequences to produce amplicons; and (f) detecting the amplicons on the surface of a nucleic acid array.Type: GrantFiled: November 30, 2017Date of Patent: November 17, 2020Assignee: Illumina, Inc.Inventors: Arnold Oliphant, John R. Stuelpnagel, Mark S. Chee, Scott L. Butler, Jian-Bing Fan, Min-Jui Richard Shen
-
Patent number: 10837047Abstract: The present disclosure provides systems and methods for making a hydrogel comprising a cell, cell nucleus, or one or more components derived from a cell or cell nucleus. A method for making a hydrogel may comprise providing a cell or cell nucleus, a first polymer, wherein the first polymer comprises a plurality of first crosslink precursors, each of the plurality of first crosslink precursors comprising an azide group; providing a second polymer, wherein the second polymer comprises a plurality of second crosslink precursors, each of the plurality of second crosslink precursors comprising an alkyne group; and crosslinking the first polymer and the second polymer via a reaction between a first section of the first crosslink precursors and a second section of the second crosslink precursors, thereby providing the hydrogel comprising the cell or cell nucleus.Type: GrantFiled: April 3, 2019Date of Patent: November 17, 2020Assignee: 10X Genomics, Inc.Inventors: Joshua Delaney, Shalini Gohil, Christopher Hindson, Adam Lowe, Andrew D. Price, Joseph Francis Shuga
-
Patent number: 10835621Abstract: The present invention relates to a bicistronic expression vector for silencing a gene specifically in astrocytes and neurons, comprising two expression cassettes comprising a first and a second silencer sequence, respectively, wherein the expression of said first silencer sequence within astrocytes is regulated by an astrocyte-specific promoter and the expression of said second silencer sequence within neurons is regulated by a neuron-specific promoter. In a preferred embodiment, said first and second silencer sequences are SOD1 silencer sequences. Pharmaceutical composition comprising said bicistronic vector and the use of the same in the treatment of motoneuron diseases are further described.Type: GrantFiled: July 22, 2016Date of Patent: November 17, 2020Assignee: Ecole Polytechnique Federale De Lausanne (EPFL)Inventors: Julianne Aebischer, Bernard Schneider, Cylia Rochat
-
Patent number: 10837905Abstract: According to one embodiment, an optical sensor is disclosed. The sensor includes a bandpass filter which transmits light in a first wavelength band including a first wavelength, and includes a transmittance distribution of the light in the first wavelength band. The transmittance distribution has a maximal value at the first wavelength. The sensor further includes a notch filter which blocks transmission of light in a second wavelength band including a second wavelength shorter than the first wavelength, and includes a transmittance distribution of light in the second wavelength band. The transmittance distribution has a first minimal value at the second wavelength.Type: GrantFiled: March 13, 2019Date of Patent: November 17, 2020Assignee: KABUSHIKI KAISHA TOSHIBAInventors: Yosuke Akimoto, Kaita Imai, Shouhei Kousai
-
Patent number: 10829801Abstract: The present invention provides compositions, kits and methods for the selective hybridization and capture of a specific target nucleic acid. The specific target nucleic acid may be present in a heterogeneous mixture of nucleic acids. Selective hybridization and capture provides a target nucleic acid that is substantially free of non-target and/or contaminating nucleic acids. Target nucleic acids that have been selectively hybridized and captured using the current invention are then used in subsequent analysis, wherein the presence of non-target and/or contaminating nucleic acids that interfere with said subsequent analysis have been substantially reduced or eliminated, thereby providing improved analysis results.Type: GrantFiled: September 18, 2017Date of Patent: November 10, 2020Assignee: GEN-PROBE INCORPORATEDInventors: Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam
-
Patent number: 10829809Abstract: The present invention is intended to provide a method of amplifying a target gene without bias and an adapter DNA use therefor. The adapter DNA of the present invention is double-stranded adapter DNA, which is used for unbiased gene amplification.Type: GrantFiled: February 23, 2016Date of Patent: November 10, 2020Assignee: TOHOKU UNIVERSITYInventor: Koetsu Ogasawara
-
Patent number: 10829760Abstract: The present invention relates to an RNAi-inducing nucleic acid molecule having a new structure and the use thereof, and more particularly to a novel nucleic acid molecule having a structure comprising a first strand, which is 24-121 nt in length and comprises a region complementary to a target nucleic acid, and a second strand which is 13-21 nt in length and has a region that binds complementarily to the region of the first strand, which is complementary to the target nucleic acid, so that the nucleic acid molecule inhibits the expression of a target gene with increased efficiency, and to a method of inhibiting the expression of a target gene using the nucleic acid molecule. The nucleic acid molecule structure of the present invention increases the efficiency with which the nucleic acid molecule inhibits the target gene.Type: GrantFiled: December 14, 2018Date of Patent: November 10, 2020Assignee: Olix Pharmaceuticals, Inc.Inventor: Dong Ki Lee
-
Patent number: 10829822Abstract: The present invention provides a method for evaluating the efficacy of an EGFR-TKI treatment to a subject, comprising identifying the V384D mutation in said subject. By identifying said mutation, the efficacy of the EGFR-TKI treatment and the progression-free survival of said subject after treatment can be estimated.Type: GrantFiled: September 21, 2018Date of Patent: November 10, 2020Assignee: LIHPAO LIFE SCIENCE CORP.Inventors: Teh-Ying Chou, Chun-Ming Tsai
-
Patent number: 10822607Abstract: A method for the generation of a G-quadruplex structure on a target nucleic acid sequence is presented. The approach combines the specificity of Watson-Crick base pair with the stability associated with a robust G-quadruplex scaffold. The induction of such bimolecular quadruplex-duplex hybrids can be applied within the antigene or antisense context for enhanced steric blockage to the transcriptional or translational machinery. In addition, such structures provide unique features for ligand design. This approach also allows the site-specific generation of G-quadruplex structures within nucleic acid nanoarchitectures.Type: GrantFiled: December 20, 2013Date of Patent: November 3, 2020Assignee: Nanyang Technological UniversityInventors: Anh Tuan Phan, Kah Wai Lim
-
Patent number: 10822648Abstract: Improved methods for amplifying target nucleic acid sequences are provided by 1) first amplifying the number of copies of target nucleic acid sequences in a sample by a first nucleic acid amplification method, and then 2) applying a second nucleic amplification method to the amplified sample, or aliquot thereof, further amplifying the number of copies of target sequences. In embodiments, a first nucleic acid amplification method is a thermocycling method, and a second nucleic acid amplification method is an isothermal method.Type: GrantFiled: July 31, 2017Date of Patent: November 3, 2020Assignee: Labrador Diagnostics LLCInventors: Pranav Patel, Indira Wu, Aaron Richardson, Zahra Kamila Belhocine, Josephine Lee, Scott Tabakman
-
Patent number: 10822588Abstract: The invention provides an isolated, purified population of human cells comprising CD8+ T cells with reduced Cbl-b activity. The invention provides uses of such cells in methods for inducing or enhancing an anti-tumor immune response in a subject. These methods comprise: (a) providing a cell population, from a subject or from another source, which comprises CD8+ T cells, (b) reducing Cbl-b activity in the CD8+ T-cells, (c) administering the cells of step (b) to the subject. The invention provides methods for making CD8+ T cells that do not require stimulation through a co-receptor in order for the cell to become activated or proliferated in response to contact via its T cell receptor. Such methods are based upon reducing function of Cbl-b. The invention also provides methods for identifying agents which affect Cbl-b expression or activity.Type: GrantFiled: September 23, 2019Date of Patent: November 3, 2020Assignees: The Trustees of Columbia University in the City of New York, The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: Hua Gu, Richard Hodes, Jeffrey J. Chiang, Ihnkyung Jang
-
Patent number: 10815486Abstract: Disclosed is an RNA aptamer, a synthetic oligonucleotide of 2?-fluoro-modified A, U, and C nucleotides, with improved stability compared to its unmodified counterpart. Like the unmodified aptamer, however, the modified version is a potent glutamate receptor antagonist. Additionally, the RNA aptamers described herein are water soluble by nature, and generally exhibit nano- to micromolar potency making them potential therapeutic agents for the treatment of neurological disorders involving glutamate receptor activity.Type: GrantFiled: July 5, 2018Date of Patent: October 27, 2020Assignee: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORKInventors: Li Niu, Zhen Huang
-
Patent number: 10815482Abstract: The present invention relates to chirally controlled oligonucleotides of select designs, chirally controlled oligonucleotide compositions, and methods of making and using the same. In some embodiments, a provided chirally controlled oligonucleotide composition provides different cleavage patterns of a nucleic acid polymer than a reference oligonucleotide composition. In some embodiments, a provided chirally controlled oligonucleotide composition provides single site cleavage within a complementary sequence of a nucleic acid polymer.Type: GrantFiled: August 22, 2018Date of Patent: October 27, 2020Assignee: WAVE LIFE SCIENCES LTD.Inventors: Meena, David Butler, Naoki Iwamoto, Nenad Svrzikapa, Gregory L. Verdine, Ivan Zlatev
-
Patent number: 10801060Abstract: Methods are provided for determining a genomic methylation profile in a DNA sample. In certain aspects, the methods can be used to determine if a subject has, or is at risk for developing, a bladder cancer or other cancers of the urinary tract. Methods for treatment of such subjects are likewise provided.Type: GrantFiled: February 24, 2016Date of Patent: October 13, 2020Assignee: ZYMO RESEARCH CORPORATIONInventors: Wei Guo, Paolo Piatti, Xiaojing Yang, Xi-Yu Jia
-
Patent number: 10793904Abstract: The invention relates to methods for pairwise sequencing of a polynucleotide template which result in the sequential determination of nucleotide sequence in two distinct and separate regions of the polynucleotide template.Type: GrantFiled: August 15, 2017Date of Patent: October 6, 2020Assignee: Illumina Cambridge LimitedInventor: Harold Philip Swerdlow
-
Patent number: 10793913Abstract: Provided are methods of treating breast cancer in a subject in need thereof comprising administering to the subject an effective amount of an inhibitor of miR-105 or an inhibitor of miR-122 are provided. Also provided herein are methods of determining a level of miR-105 or a level of miR-122 in a subject that has or is at risk for developing breast cancer. The method includes obtaining a biological sample from the subject and determining a level of miR-105 or a level of miR-122 or a combination thereof in the biological sample, wherein a higher level of miR-105 or miR-122 as compared to a control indicates that the subject has or is at risk of developing breast cancer.Type: GrantFiled: March 10, 2014Date of Patent: October 6, 2020Assignee: City of HopeInventors: Shizhen Emily Wang, Xiwei Wu
-
Patent number: 10793841Abstract: The present invention provides engineered T7 RNA polymerase variants and compositions thereof. These variants have been evolved for selective incorporation of the symmetrical capped GTP analog over GTP at the initiation of in vitro transcription. The present invention also provides methods for using the variants provided herein. The present invention further provides for the use of the compositions provided herein.Type: GrantFiled: June 19, 2018Date of Patent: October 6, 2020Assignee: Codexis, Inc.Inventors: Mathew G. Miller, Chinping Chng, Oscar Alvizo, Melissa Ann Mayo, James Nicholas Riggins, Xiang Yi, Jonathan S. Penfield, Gjalt W. Huisman
-
Patent number: 10787573Abstract: Multimeric protected fluorescent reagents and their methods of synthesis are provided. The reagents are useful in various fluorescence-based analytical methods, including the analysis of highly multiplexed optical reactions in large numbers at high densities, such as single molecule real time nucleic acid sequencing reactions. The reagents contain fluorescent dye elements, that allow the compounds to be detected with high sensitivity at desirable wavelengths, binding elements, that allow the compounds to be recognized specifically by target biomolecules, and protective shield elements, that decrease undesirable contacts between the fluorescent dye elements and the bound target biomolecules and that therefore decrease photodamage of the bound target biomolecules by the fluorescent dye elements. The reagents also contain coupling elements connect monomeric compounds into multimeric forms, thereby increasing brightness.Type: GrantFiled: December 4, 2018Date of Patent: September 29, 2020Assignee: Pacific Biosciences of California, Inc.Inventors: Frank Zheng, Jeremiah Hanes, Gene Shen, Louis Brogley, Stephen Yue, Yuri Lapin, John Lyle, Honey Osuna, Andrei Fedorov, Lubomir Sebo
-
Patent number: 10781453Abstract: A non-human animal (e.g., a rodent) model for diseases associated with a C9ORF72 heterologous hexanucleotide repeat expansion sequence is provided, which non-human animal comprises a heterologous hexanucleotide repeat (GGGGCC) in an endogenous C9ORF72 locus. A non-human animal disclosed herein comprising a heterologous hexanucleotide repeat expansion sequence comprising at least one instance, e.g., repeat, of a hexanucleotide (GGGGCC) sequence may further exhibit a characteristic and/or phenotype associated with one or more neurodegenerative disorders (e.g., amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD), etc.). Methods of identifying therapeutic candidates that may be used to prevent, delay or treat one or more neurodegenerative (e.g., amyotrophic lateral sclerosis (ALS, also referred to as Lou Gehrig's disease) and frontotemporal dementia (FTD)) are also provided.Type: GrantFiled: September 29, 2017Date of Patent: September 22, 2020Assignee: Regeneron Pharmaceuticals, Inc.Inventors: David Heslin, Roxanne Ally, Chia-Jen Siao, Ka-Man Venus Lai, David M. Valenzuela, Aarti Sharma-Kanning, Daisuke Kajimura, Gustavo Droguett, David Frendewey, Alexander O. Mujica
-
Patent number: 10774369Abstract: The present disclosure provides systems and methods for making a hydrogel comprising a cell, cell nucleus, or one or more components derived from a cell or cell nucleus. A method for making a hydrogel may comprise providing a cell or cell nucleus, a first polymer, wherein the first polymer comprises a plurality of first crosslink precursors, each of the plurality of first crosslink precursors comprising an azide group; providing a second polymer, wherein the second polymer comprises a plurality of second crosslink precursors, each of the plurality of second crosslink precursors comprising an alkyne group; and crosslinking the first polymer and the second polymer via a reaction between a first section of the first crosslink precursors and a second section of the second crosslink precursors, thereby providing the hydrogel comprising the cell or cell nucleus.Type: GrantFiled: April 3, 2019Date of Patent: September 15, 2020Assignee: 10X Genomics, Inc.Inventors: Joshua Delaney, Shalini Gohil, Christopher Hindson, Adam Lowe, Andrew D. Price, Joseph Francis Shuga
-
Patent number: 10774376Abstract: The present invention provides systems, devices, methods, kits, and compositions for nucleic acid analysis using digital PCR. In particular, methods are provided to analyze high titer samples that cannot be divided into a sufficient number of partitions containing zero nucleic acid molecules per partition to allow for Poisson analysis (digital PCR analysis).Type: GrantFiled: December 28, 2015Date of Patent: September 15, 2020Assignee: ABBOTT MOLECULAR INC.Inventors: John M. Clemens, Eric B. Shain
-
Patent number: 10774325Abstract: There is disclosed a process for in vitro synthesis and assembly of long, gene-length polynucleotides based upon assembly of multiple shorter oligonucleotides synthesized in situ on a microarray platform. Specifically, there is disclosed a process for in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, “on device” assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments.Type: GrantFiled: February 18, 2020Date of Patent: September 15, 2020Assignee: Gen9, Inc.Inventor: Andrew V. Oleinikov
-
Patent number: 10774107Abstract: Novel compositions and methods for engineering wireframe architectures and scaffolds of increasing complexity by creating gridiron-like DNA structures (FIG. 1). A series of four-arm junctions are used as vertices within a network of double-helical DNA fragments. Deliberate distortion of the junctions from their most relaxed conformations ensures that a scaffold strand can traverse through individual vertices in multiple directions. DNA gridirons, ranging from two-dimensional arrays with reconfigurability to multilayer and three-dimensional structures and curved objects, can be assembled according the methods presented herein.Type: GrantFiled: November 28, 2018Date of Patent: September 15, 2020Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITYInventors: Dongran Han, Hao Yan
-
Patent number: 10774322Abstract: Disclosed are methods for lysis of cells, such as bacteria present in microbiomes, that combine three lysis steps—(1) heat, (2) detergent and (3) base—into a single step and that can be completed in a short period of time, e.g., a few minutes. The methods combine a normally incompatible detergent and base lysis, allows for simplified removal of detergent after lysis, and importantly, yields improved quantities of genomic DNA (gDNA) from difficult to lyse bacteria.Type: GrantFiled: December 26, 2017Date of Patent: September 15, 2020Assignee: Shoreline Biome, LLCInventors: Mark Driscoll, Thomas Jarvie
-
Patent number: 10774384Abstract: Contemplated systems and methods allow for computational genomic analysis using paired-end sequence analysis and split read refinement to thereby identify high-confidence breakpoints associated with high copy numbers and orientation of rearrangements, which is then the basis for full reconstruction of double minutes (DM). In especially preferred aspects, the DM will also include an oncogene or tumor suppressor gene, and/or may be found in blood or blood derived fluids.Type: GrantFiled: April 15, 2016Date of Patent: September 15, 2020Assignee: Five3 Genomics, LLCInventors: John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz
-
Patent number: 10768169Abstract: The present invention relates to a method for determining the distinctive nutritional requirements of a patient with specific nutritional needs and providing a composition meeting the distinctive nutritional requirements of said patient.Type: GrantFiled: January 22, 2016Date of Patent: September 8, 2020Assignee: Societe des Produits Nestle S.A.Inventors: Serge Andre Dominique Rezzi, Stephanie Blum-Sperisen, Magali Faure, Denis Breuille
-
Patent number: 10767278Abstract: Provided herein are encoded split pool libraries useful, inter alia, for forming highly diverse and dense arrays for screening and detection of a variety of molecules.Type: GrantFiled: August 29, 2019Date of Patent: September 8, 2020Assignee: City of HopeInventors: Jacob Berlin, Gregory Copeland, Kathleen Elison, Hurik Muradyan
-
Patent number: 10760181Abstract: Provided herein are encoded split pool libraries useful, inter alia, for forming highly diverse and dense arrays for screening and detection of a variety of molecules.Type: GrantFiled: February 24, 2016Date of Patent: September 1, 2020Assignee: City of HopeInventors: Jacob Berlin, Gregory Copeland, Kathleen Elison, Hurik Muradyan
-
Patent number: 10752942Abstract: In some aspects, the present disclosure provides methods for enriching amplicons, or amplification products, comprising a concatemer of at least two or more copies of a target polynucleotide. In some embodiments, a method comprises sequencing the amplicons comprising at least two or more copies of a target polynucleotide. In some embodiments, the target polynucleotides comprise sequences resulting from chromosome rearrangement, including but not limited to point mutations, single nucleotide polymorphisms, insertions, deletions, and translocations including fusion genes. In some aspects, the present disclosure provides compositions and reaction mixtures useful in the described methods.Type: GrantFiled: April 6, 2018Date of Patent: August 25, 2020Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Shengrong Lin, Ling Fung Tang
-
Patent number: 10755805Abstract: Presenting ancestral origin information, comprising: receiving a request to display ancestry data of an individual; obtaining ancestry composition information of the individual, the ancestry composition information including information pertaining to a proportion of the individual's genotype data that is deemed to correspond to a specific ancestry; and presenting the ancestry composition information to be displayed.Type: GrantFiled: June 19, 2019Date of Patent: August 25, 2020Assignee: 23andMe, Inc.Inventors: Chuong Do, Eric Durand, John Michael Macpherson
-
Patent number: 10745702Abstract: The invention relates to antisense polynucleotide agents targeting the LECT2 gene, and methods of using such antisense polynucleotide agents to inhibit expression of LECT2 and to treat subjects having a LECT2-associated disease, e.g., amyloidosis.Type: GrantFiled: April 8, 2016Date of Patent: August 18, 2020Assignee: ALNYLAM PHARMACEUTICALS, INC.Inventor: Gregory Hinkle
-
Patent number: 10745748Abstract: In some embodiments, a variety of devices and methods for conducting microfluidic analyses are utilized herein, including devices that can be utilized to conduct thermal cycling reactions such as nucleic acid amplification reactions. The devices include elastomeric components; in some instances, much or all of the device is composed of elastomeric material. Amplification products (amplicons) can be detected and distinguished (whether isolated in a reaction chamber or at any subsequent time) using routine methods for detecting nucleic acids. An example of a detection method includes hybridization to arrays of immobilized oligo or polynucleotides.Type: GrantFiled: September 18, 2018Date of Patent: August 18, 2020Assignee: FLUIDIGM CORPORATIONInventors: Marc A. Unger, Geoffrey Richard Facer, Barry Clerkson, Christopher G. Cesar, Neil Switz
-
Patent number: 10745697Abstract: The invention relates to a method for genotyping individuals, through multiplexing genotyping, when samples carrying different loci of various individuals are pooled and genotyping is performed on this pool.Type: GrantFiled: January 9, 2015Date of Patent: August 18, 2020Assignee: LIMAGRAIN EUROPEInventors: Jean-Pierre Martinant, Pascal Flament
-
Patent number: 10738349Abstract: This disclosure relates DNA based movement of objects. In certain embodiments, particles, pairs of particles, or a rods are conjugated with single stranded DNA that hybridizes to a single stranded RNA that is conjugated to a substrate. When the DNA particle, pair of particles, or rod interacts with the surface RNA in the presence of an endonuclease, such as RNase H and the DNA hybridizes to the RNA, then the particle, pair of particle, or rod moves along the surface. The complementarity of the DNA and RNA affect the velocity.Type: GrantFiled: October 24, 2016Date of Patent: August 11, 2020Assignee: Emory UniversityInventors: Khalid Salaita, Kevin Yehl
-
Patent number: 10738347Abstract: Provided herein are reagents and kits for detection of multiple target sequences in a single-tube, single-color assay, and methods of use thereof. In particular, multiplex assays are provided for the detection of Mycobacterium tuberculosis complex target sequences (e.g., katG, rpoB, inhA promotor, pncA, etc.).Type: GrantFiled: November 18, 2014Date of Patent: August 11, 2020Assignee: Brandeis UniversityInventors: Lawrence J. Wangh, Kenneth E. Pierce, John E. Rice
-
Patent number: 10739293Abstract: A method and device for performing DNA sequencing and extracting structural information from unknown nucleic acid strands. The device includes a microwell structure, where identical DNA strands are immobilized within the microwell structure on a surface of a micro-bead, an active electrode or a porous polymer. The device further includes a CMOS-integrated semiconductor integrated circuit, where the CMOS-integrated semiconductor integrated circuit includes metal layers on a silicon substrate, where the metal layers form an active electrode biosensor. In addition, a sensing electrode is formed by creating openings in a passivation layer of the CMOS-integrated semiconductor integrated circuit to hold a single bead, on which the DNA strands are immobilized.Type: GrantFiled: April 12, 2016Date of Patent: August 11, 2020Assignee: Board of Regents, The University of Texas SystemsInventors: Arjang Hassibi, Arun Manickam, Rituraj Singh
-
Patent number: 10733438Abstract: An eyeball information detection device includes: an acquisition unit configured to acquire a captured image obtained by imaging a region in which there is a probability that a face of an occupant is present in a vehicle by an imaging device provided in proximity to an illumination device that emits light to the region; and a detection unit configured to output eyeball information that corresponds to the captured image by receiving the captured image acquired by the acquisition unit as an input based on a learned model generated by learning a learning image including information similar to the captured image acquired by the acquisition unit and a correct value of the eyeball information on an eyeball of the occupant appearing in the learning image, by machine learning.Type: GrantFiled: September 23, 2019Date of Patent: August 4, 2020Assignee: AISIN SEIKI KABUSHIKI KAISHAInventors: Shin Osuga, Takashi Kato, Yuya Yamada, Yuta Kawai
-
Patent number: 10724081Abstract: Methods and containers are provided for identifying a species, illustratively a bacterial species. Illustrative methods comprise amplifying various genes in the nucleic acid from the bacterial species in a single reaction mixture using pairs of outer first-stage primers designed to hybridize to generally conserved regions of the respective genes to generate a plurality of first-stage amplicons, dividing the reaction mixture into a plurality of second-stage reactions, each using a unique pair of second-stage primers, each pair of second-stage primers specific for a target bacterial species or subset of bacterial species, detecting which of the second-stage reactions amplified, and identifying the bacterial species based on second-stage amplification.Type: GrantFiled: July 26, 2017Date of Patent: July 28, 2020Assignees: BioFire Diagnostics, LLC, University of Utah Research FoundationInventors: Mark Aaron Poritz, Anne Jeannette Blaschke-Bonkowsky
-
Patent number: 10725058Abstract: The subject invention provides methods, assays, and products for visual detection of small-molecule targets in a sample in both clinical and field settings within minutes. The subject invention is based on an aptamer sensor that reports the presence of small-molecule target via a sensitive colorimetric signal for naked-eye detection. The aptamer sensor is a CBSAzyme-based sensor having both target-mediated cooperative behavior of the CBSA and peroxidase-mimicking catalytic activity of DNAzyme. The subject invention also provides methods of using the CBSAzyme-based sensor.Type: GrantFiled: November 2, 2018Date of Patent: July 28, 2020Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEESInventors: Yi Xiao, Yingping Luo, Haixiang Yu
-
Patent number: 10724074Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample and for stabilizing the transcriptome of contained cells.Type: GrantFiled: September 25, 2013Date of Patent: July 28, 2020Assignee: Qiagen GmbHInventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels, Kalle Günther, Ralf Wyrich, Uwe Oelmüller